10/05/2015
On October 1, changes will go into effect for Connecticut’s prescription drug monitoring program (PDMP) that will add additional physician requirements and make it harder for individuals living with epilepsy to access anti-epilepsy drugs (AEDs). The changes will require prescribers to check the PDMP database when prescribing more than a 72-hour fill every 90 days for a Schedule II-V drug, which many epilepsy drugs are. This additional step is time consuming and unnecessary when physicians are prescribing AEDs given that people living with epilepsy are not abusing their medications. Take a moment and urge the government to remove these barriers to epilepsy care by exempting all Schedule V AEDs from these new monitoring requirements.
Individuals living with epilepsy who experience a delay in accessing their medication due to onerous drug monitoring requirements are at a high risk for developing breakthrough seizures and related complications. Delays also significantly increase medical costs related to preventable seizures, along with lost wages and productivity, not just for the individuals living with epilepsy, but also their families and communities.
The Epilepsy Foundation and the Epilepsy Foundation of Connecticut strongly believe that including Schedule V AEDs in the new monitoring program requirements will endanger the health and privacy of individuals with epilepsy and have urged the Governor to to exempt Schedule V AEDs.
Go here to contact the Governor today and ask him to exempt Schedule V AEDs from the upcoming changes to the prescription drug monitoring program in order to preserve and protect access to medications and privacy for individuals living with epilepsy in Connecticut:
« Back To All News
© 2021 Epilepsy Foundation Connecticut
